Beyond the LabelSign in
theskindex
Tuesday, October 13, 2026Index last updated Oct 9
The Index  ·  Synthetic prostaglandin analogue

Isopropyl Cloprostenate

Isopropyl Cloprostenate

Prostaglandin analogue in some lash serums; EU SCCS said it is not safe for eyelash/eyebrow growth cosmetics, while a US Panel draft tentative report is still open.

EmergingSCCS: not safe for lash/brow growth cosmetics; CIR US conclusion still TBD.
Sign in to save and follow
Written byTheSkindex Desk
Reviewed byNot yet reviewed
Last updated18 Sept 2026
Sources2 cited

Isopropyl Cloprostenate is a synthetic prostaglandin analogue listed as a hair-conditioning agent. CIR is reviewing it with ethyl Tafluprostamide; the EU SCCS has already assessed it among three PGAs used for lash and brow growth.[1][2]

What it does

Like other cosmetic PGAs, it is positioned for eyelash and eyebrow appearance via prostaglandin pathways that can also affect the eye and periocular fat.[1][2]

The evidence

CIR’s revised Draft Tentative Report (11 September 2026) follows multiple insufficient-data rounds, including requests for dermal irritation/sensitisation at up to 0.0075% and independent ophthalmology review of iris-colour and related ocular endpoints.[1] SCCS/1680/25 (final 2 February 2026) concluded that isopropyl cloprostenate, methylamido-dihydro-noralfaprostal, and dechloro dihydroxy difluoro ethylcloprostenolamide cannot be considered safe for cosmetic products intended to promote eyelash or eyebrow growth.[2]

How to use it

Read the INCI on lash serums. In the EU, the SCCS opinion is a clear negative for growth-claim use of this analogue; in the US, wait for CIR’s tentative conclusion rather than assuming a Dictionary “conditioning” function equals a clean safety pass.

Evidence by claim

Graded separately; the entry grade is the best-supported claim
Used in some eyelash/eyebrow formulas; SCCS judged not safe for growth-claim cosmetics[1][2]
Emerging

Safety & limits

Source and region, always
eyelash and eyebrow growth products — SCCS/1680/25: not considered safe for cosmetic products intended to promote eyelash or eyebrow growth.[2] EU
0.008 % · cosmetic use cited in CIR IDA — CIR Draft Tentative Report (Sep 2026) — conclusion to be determined; prior IDA referenced 0.0075% maximum use concentration.[1] US

Sources · 2

Numbered as cited in the text
  1. [1]Revised Draft Tentative Report: Safety Assessment of Ethyl Tafluprostamide and Isopropyl Cloprostenate as Used in Cosmetics. Cosmetic Ingredient Review (2026)
  2. [2]SCCS / European Commission. Opinion on prostaglandin analogues used in cosmetic products (SCCS/1680/25). SCCS (2026)

Revision history

18 Sept 2026Drafted by botTheSkindex Desk